
|Articles|October 26, 2015
Laura Tang on Classifications of Neuroendocrine Tumors
Author(s)Laura Tang, MD, PhD
Laura Tang, MD, PhD, a pathologist at Memorial Sloan Kettering Cancer Center, discusses the classifications of advanced neuroendocrine tumors (NETs).
Advertisement
Laura Tang, MD, PhD, a pathologist at Memorial Sloan Kettering Cancer Center, discusses the classifications of advanced neuroendocrine tumors (NETs).
NETs are classified as well-differentiated or poorly-differentiated.
Patients with well-differentiated, high grade (G3) NETs generally do not experience symptoms and their tumors are often diagnosed incidentally.
Patients with poorly-differentiated tumors are typically very ill and present with dramatic symptoms such as abdominal pain, weight loss, and jaundice.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Camizestrant Approval: Nurses Key to New Breast Cancer Paradigm
2
Nursing Protocols for the New Oral RAS Inhibitor Daraxonrasib
3
FDA Approves Iberdomide: A New Oral Paradigm in Multiple Myeloma Care
4
How the Emerging MPN Pipeline Will Reshape PV Nursing and Patient Care
5



























































